Management of Congestive Heart Failure and Pulmonary Edema

Year 2019, Volume: 1 Issue: 1, 45 - 50, 23.04.2019

Ramazan Güven

Abstract

Congestive heart failure (CHF) is one of the
most important challenge received by emergency physcians. Current review
describes the management of CHF and pulmonary edema based on the latest
updates, with a priority in the 2016 guidelines of the European Society of
Cardiology (ESC). In the latest guidelines, they were more algorithmic approach
than previous ones. The importance of step treatment was
emphasized based on these algorithms.  It was seen that treatment and
management were done with prognostic classifications especially
Nohria-Stevenson classification.

Keywords

Congestive Heart Failure, Pulmonary Edema

References

• 1. Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D et al. Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community. JACC Heart Fail 2016;4:808–15.2. Figueroa MS and Peters JI. Congestive Heart Failure: Diagnosis, Pathophysiology, Therapy, and Implications for Respiratory Care. Respir Care 2006;51(4):403-12.3. Değertekin M, Erol Ç, Ergene O, Tokgözoğlu L, Aksoy M, Erol MK et al. Türkiye’deki kalp yetersizliği prevalansı ve öngördürücüleri: HAPPY çalışması. 2012; 40(4):298-308 4. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129–200.5. Sarı İ, Çavuşoğlu Y, Temizhan A, Yılmaz MB ve Eren M. 2016 Avrupa ve Amerika Kalp Yetersizliği Klavuz Güncellemeleri: Yenilikler, benzerlikler, farklılıklar ve netlik kazanmış konular. Turk Kardiyol Dern Ars 2016;44(8):625-366. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Disease of the Heart and Hreat Vessels. 9th ed. Boston, Mass: Little, Brown&Co;1994:253-67. Sagawa K, Suga H, Shoukas AA and Bakalar KM. End-systolic pressure/volume ratio: a new index of ventricular contractility. Am J Cardiol 1977;40:748-538. Reddi BA, Shanmugam N and Fletcher N. Heart failure-pathophysiology and inpatient management. BJA Education, 2017;17(5):150-60 9. Guadalajara-Boo JF. Undergstanding Heart Failure. Int J Cardiovasc Res 2016;6:110. Sandler H and Dodge HT. Left ventricular tension and stress in man. Circ 1963;13:91-10411. Gunther S and Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979;59:679-8812. Francis GS and Tang WHW. Pathophysiology of Congestive Heart Failure. Rev Cardiovasc Med. 2003;4(suppl 2):14-2013. Dosh SA. Diagnosis of heart failure in adults. Am Fam Physcian. 2004;70(11):2145-5214. Institute for Clinical Systems Improvement (ICSI). Heart failure in adults. Bloomington, Minn.:Institute for Clinical Systems Improvement (ICSI); 2009:9515. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D et al. Predictors of heart failure among women with coronary disease. Circulation 2004;110(11):1424-3016. Peacock WF, De Marco T, Fonarow GC, Dierecks D, Wynne J, Apple FS et al. Cardiac Troponin and Outcome in Acute Heart Failure. N Engl J Med 2008;358:2117-26.17. Rhee C. Using Procalcitonin to Guide Antibiotic Therapy. Open Forum Infect Dis. 2017;4(1)18. Vital FMR, Ladeira MT, Atallah AN. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrange Database Syst Rev 2013;5:CD00535119. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364:797–805.20. Ural D, Çavuşoğlu Y, Eren M, Karaüzüm K, Temizhan A, Yılmaz MB et al. Diagnosis and management of acute heart failure. Anatol J Cardiol 2015;15:860-89.21. Cavusoglu Y. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure. Expert Opin Pharmacother 2007; 8: 665-77.22. Gruhn N, Nielsen-Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 1998; 31: 741-9.23. Landoni G, Biondi-Zoccai G, Greco M, Greco T, Bignami E, Morelli A, et al. Effects of levosimendan on mortality and hospitalization A meta-analysis of randomized controlled studies. Crit Care Med 2012; 40: 634-46.24. Iakobishvili Z, Cohen E, Garty M, Behar S, Shotan A, Sandach A, et al. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Acute Card Care 2011;13:76–80.25. Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 2010;16:277–284.